Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Accumulated Expenses (2022 - 2025)

Argan's Other Accumulated Expenses history spans 4 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 40.81% year-over-year to $7.5 million; the TTM value through Oct 2025 reached $7.5 million, down 40.81%, while the annual FY2025 figure was $19.2 million, 122.06% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $7.5 million at Argan, down from $18.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $25.6 million in Q2 2025 and bottomed at $7.5 million in Q4 2025.
  • The 4-year median for Other Accumulated Expenses is $12.6 million (2023), against an average of $13.1 million.
  • The largest YoY upside for Other Accumulated Expenses was 122.06% in 2025 against a maximum downside of 40.81% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $13.4 million in 2022, then dropped by 17.19% to $11.1 million in 2023, then rose by 14.39% to $12.7 million in 2024, then tumbled by 40.81% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's Other Accumulated Expenses are $7.5 million (Q4 2025), $18.4 million (Q3 2025), and $25.6 million (Q2 2025).